Compass Therapeutics
compasstherapeutics.com · 52 people
- Open roles
- 1
- Remote
- 0
- Headcount
- 52
- Offices
- 1
About Compass Therapeutics
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’ scientific focus is on the relationship between angiogenesis, the immune system and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. To learn more, visit www.compasstherapeutics.com
Markets
Offices
Backed by
Open roles at Compass Therapeutics
- Yesterday
Apply on autopilot
Tell me once what you are looking for. Every morning I rank the whole catalog against your profile, pick the openings worth your time, and prepare a tailored resume and cover letter for each one.
Applications finish as drafts. Nothing is sent until you read it and press send. New accounts start with 500 free credits.
Counted from the job board Compass Therapeutics publishes. Refolk is not affiliated with Compass Therapeutics and does not handle their hiring.